EDITORIAL
Quality of Life data in immune oncology trials: from side note to centre stage?
Despite greater attention being given to treatment effects on patient wellbeing, the high heterogeneity of methodologies still limits the usefulness of QoL assessment
ESMO GASTROINTESTINAL CANCERS CONGRESS 2025
ctDNA testing may help refine surveillance strategy for colorectal cancer
Study findings show that ctDNA is a stronger biomarker than carcinoembryonic antigen to select patients who may benefit from metastasis-directed therapy
Promising activity reported for olaparib in advanced biliary tract cancers
Study indicates that PARP inhibition could extend treatment options for patients with biliary tract cancers
Prolonged intertreatment interval improves outcomes to EGFR rechallenge in metastatic colorectal cancer
Randomised trials and real-world data propel the anti-EGFR rechallenge approach towards standard of care, but more solid evidence is needed
AI & DIGITAL ONCOLOGY
AI-driven tool shows to improve risk stratification in colorectal cancer
A system integrating computer tomography scans and pathological markers offers promise to personalise adjuvant therapy
Embracing interdisciplinary collaboration for an AI-driven oncology
ESMO now welcomes members from other disciplines to support and expedite the digital transformation of cancer care
AI is transforming cancer diagnosis, but systemic barriers still hold it back
A new ESMO systematic review maps AI’s growing role in pathology and oncology, as well as challenges in its implementation due to infrastructure, regulatory framework and human factors
OPINIONS
ctDNA and RNA-based tests are expanding colorectal cancer screening options
Frank A. Sinicrope
Decoding genomic and transcriptomic signatures in colorectal cancer – next steps?
Federica Di Nicolantonio
Advancing perioperative treatment in resectable non-small cell lung cancer
Marina Chiara Garassino
Early data presented for a biomarker-guided care of metastatic hormone-sensitive prostate cancer
Elena Castro
Challenging ageism in gynaecological cancers
Elene Mariamidze
OPINIONS
ctDNA and RNA-based tests are expanding colorectal cancer screening options
Frank A. Sinicrope
Decoding genomic and transcriptomic signatures in colorectal cancer – next steps?
Federica Di Nicolantonio
Advancing perioperative treatment in resectable non-small cell lung cancer
Marina Chiara Garassino
Early data presented for a biomarker-guided care of metastatic hormone-sensitive prostate cancer
Elena Castro
Challenging ageism in gynaecological cancers
Elene Mariamidze